Anbio Biotechnology: xbrl:EarningsPerShareDiluted
| Value | {"per": "shares", "amount": 0.056, "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/4c425a20-0ecd-4c1a-be4c-5383697c5c24
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/4c425a20-0ecd-4c1a-be4c-5383697c5c24
History
- no predecessors — first report